Challenges and solutions: The present and future of cell therapies for T1D
Breakthrough T1D is funding research that supports manufactured islet cell source, survival, and protection and is also driving initiatives to unlock access to manufactured islet therapies for people with T1D.
Medical Affairs: Closing the gap between access and adoption
Breakthrough T1D's new Medical Affairs unit will address the numerous challenges contributing to the slow adoption of groundbreaking T1D therapies.
Cell therapies 101: What are stem cells and why do they matter?
Researchers are harnessing the power of stem cells to generate functional beta cells and islets, driving us closer toward type 1 diabetes cures.
Cell therapy first: transplanted islets working without immunosuppressives
The recipient of gene-edited islets to evade the immune system is making insulin without the use of immunusuppresives.
